Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gaia Herbs helps “brick-and-mortar” outlets

This article was originally published in The Tan Sheet

Executive Summary

Gaia Herbs' win against the antitrust lawsuit filed by Vitacost.com "serves to ensure traditional 'brick-and-mortar' natural products stores that competition from online mass market discounters will not factor" into potential sales for the herbal manufacturer's product line, Gaia states in a June 13 release. The U.S. District Court of the Southern District of Florida dismissed the case in March and decided the firm did not violate state antitrust laws by refusing to do business with Vitacost.com because the e-commerce firm did not agree to Gaia's mandated minimum resale price for its products (1"The Tan Sheet" April 30, 2007, p. 15). Gaia implemented a policy to not sell its products to online retailers that do not also have brick-and-mortar establishments in January...

You may also be interested in...



Gaia Herbs Suit Dismissal Highlights Antitrust Law Awareness

Dietary supplement firms must be aware of antitrust laws when implementing pricing policies, according to an attorney who represented Gaia Herbs in a lawsuit filed against it by e-commerce firm Vitacost.com

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.

Topics

UsernamePublicRestriction

Register

PS100617

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel